Teva publishes 2021 esg progress report, showcasing further integration of esg into business, robust targets and strengthened esg governance structure

Tel aviv, israel--(business wire)--teva pharmaceutical industries ltd. (nyse and tase: teva), a leading global pharmaceutical company providing medicines to nearly 200 million people daily, published its 2021 esg progress report today. the report details how teva further integrated esg into its business strategy—implementing a strengthened esg governance structure and setting 13 ambitious targets related to access to medicines, ethics, environment and responsible supply chain, some of which are
TEVA Ratings Summary
TEVA Quant Ranking